William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
The AZEK® Company Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
B. Riley Financial Announces Closing of $200 Million Offering of Senior Notes Due 2028
-
ON24 Announces Launch of Initial Public Offering
-
The AZEK Company Inc. (AZEK) Prices 20M Share Common Offering at $40/Sh
-
InVitae (NVTA) Prices 7.77M Share Common Offering at $51.50/Sh
-
The AZEK® Company Announces Pricing of Public Offering of Class A Common Stock
-
Invitae Announces Pricing of Public Offering of Common Stock
-
CarLotz, Inc. Closes Business Combination and Will Trade on the Nasdaq Stock Exchange Under the Ticker LOTZ
-
CarLotz, Inc. Closes Business Combination and Will Trade on the Nasdaq Stock Exchange Under the Ticker LOTZ
-
Penn Foster Secures Investment to Accelerate Pairing of Data Science with Skills-Based Digital Learning
-
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
-
B. Riley Financial Announces Pricing of $200 Million Offering of Senior Notes Due 2028
-
Aclaris Therapeutics (ACRS) Prices 5.48M Share Common Stock Offering at $17.50/sh
-
Aclaris Announces Pricing of Public Offering of Common Stock
-
Mycocycle Named to Startup Chicago Inaugural Class of Companies
-
B. Riley Financial Announces Offering of $100 Million Senior Notes Due 2028 and "BBB+" Rating from Egan-Jones
-
UPDATE: William Blair Starts Palantir Technologies Inc. (PLTR) at Market Perform; 'Best-in-Class Data Integration and Analytics Solution'
-
Signify Health Files Registration Statement for Proposed Initial Public Offering
-
Aclaris Therapeutics (ACRS) Announces Proposed Public Offering of Common Stock
-
Aclaris Announces Proposed Public Offering of Common Stock
-
Signet Healthcare and Bionpharma Sell CoreRx, a Leading Contract Development and Manufacturer
-
Signet Healthcare and Bionpharma Sell CoreRx, a Leading Contract Development and Manufacturer
-
Beam Therapeutics Inc. (BEAM) Announces $260 Million Common Stock Investment from Multiple Investors
-
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
-
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
-
NovaQuest Private Equity Acquires CoreRx, Inc.
-
Franchise Group, Inc. Closes Preferred Stock Offering
-
Form D WILLIAM BLAIR MB INVESTM
-
Driven Brands (DRVN) IPO Opens 27% Higher
-
Driven Brands Holdings Inc. (DRVN) Prices 31.82M Share IPO at $22/Sh
-
Driven Brands Holdings Inc. Announces Pricing of Initial Public Offering
-
Driven Brands Holdings Inc. Announces Pricing of Initial Public Offering
-
Poshmark (POSH) IPO Opens 132% Higher
-
William Blair Sees 2 Reasons the AeroVironment (AVAV) Deal Will Help Drive Shares Toward $140
-
Lemonade (LMND) Prices 3.3M Share Upsized Common Offering and 1.524M Share Secondary Offering at $165/Sh
-
Repay Holdings Corporation (RPAY) Prices 5.43M Share Common Offering at $24/Sh
-
Poshmark Inc. (POSH) Prices 6.6M Share IPO at $42/Sh
-
Poshmark, Inc. Announces Pricing of Initial Public Offering
-
REPAY Announces Pricing of Public Offering of Common Stock
-
Lemonade Announces Upsizing and Pricing of Public Offering of Common Stock
-
William Blair Downgrades VMware (VMW) to Market Perform
-
K1 Agrees to Sell Clarizen, the Category Leader in Enterprise Collaborative Work Management, to Planview
-
Analysis: The trillion dollar weapon in the U.S.-China tech stock war
-
Franchise Group, Inc. Prices $75 Million Offering of Series A Cumulative Perpetual Preferred Stock
-
loanDepot Files Registration Statement for Proposed Initial Public Offering
-
DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Franchise Group, Inc. Announces Offering of Series A Cumulative Perpetual Preferred Stock
-
Form SC 13G Star Peak Energy Transit Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Duff & Phelps Investment Management Names David Grumhaus President and Chief Investment Officer
-
Sana Biotechnology Announces Appointments to its Board of Directors

